This inventor holds 4 USPTO granted patents. Top assignees: Kuraray Co., Ltd., Kayaku Antibiotics Research Co., Ltd., Yamanouchi Pharmaceutical Company Ltd.. Active years: 1981-1988.
Company Filing History:
4 out of 1,872 
3 out of 4 
3 out of 329 Years Active: 1981-1988
Title: The Innovations of Toshihiko Yoshitake
Introduction
Toshihiko Yoshitake is a notable inventor based in Kurashiki, Japan. He has made significant contributions to the field of cancer research through his innovative work on neocarzinostatin derivatives. With a total of 4 patents to his name, Yoshitake has established himself as a key figure in the development of anticancer agents.
Latest Patents
Yoshitake's latest patents focus on the production of substantially pure neocarzinostatin anticancer agents. These agents are characterized by the formula (A) and represent a significant advancement in cancer treatment methodologies. His work in this area has the potential to improve therapeutic outcomes for patients battling cancer.
Career Highlights
Throughout his career, Yoshitake has worked with Kuraray Co., Ltd., a company known for its innovative materials and chemicals. His experience in this organization has undoubtedly contributed to his expertise in developing effective pharmaceutical solutions.
Collaborations
Yoshitake has collaborated with notable individuals in his field, including Hiroshi Maeda and Ryunosuke Kanamaru. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented inventions.
Conclusion
Toshihiko Yoshitake's contributions to cancer research through his patents on neocarzinostatin derivatives highlight his innovative spirit and dedication to improving patient care. His work continues to inspire advancements in the medical field.